Philip Alcabes

752 total citations
26 papers, 574 citations indexed

About

Philip Alcabes is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Philip Alcabes has authored 26 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 15 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Philip Alcabes's work include HIV, Drug Use, Sexual Risk (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (7 papers). Philip Alcabes is often cited by papers focused on HIV, Drug Use, Sexual Risk (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (7 papers). Philip Alcabes collaborates with scholars based in United States, India and United Kingdom. Philip Alcabes's co-authors include Gerald Friedland, Ellie E. Schoenbaum, Robert S. Klein, Peter A. Selwyn, David Vlahov, Katherine Davenny, Diana Hartel, Donna Buono, Álvaro Muñoz and James C. Anthony and has published in prestigious journals such as New England Journal of Medicine, JAMA and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Philip Alcabes

25 papers receiving 540 citations

Peers

Philip Alcabes

EPIDE

VIROL

PHEOH

SURGE

G. Friedland United States

Ann M. Labriola United States

R Boulos United States

Fiona Lyons Ireland

Giorgio Bozzi Italy

Pongsakdi Chaisilwattana Thailand

Jean‐Jacques Cheseaux Switzerland

Fizza S. Gillani United States

Valérie Lamarre Canada

Pablo F. Belaunzarán-Zamudio Mexico

G. Friedland United States

Philip Alcabes

315 ×0.8

323 ×0.9

EPIDE

169 ×1.2

VIROL

45 ×0.6

PHEOH

43 ×0.7

SURGE

Citations per year, relative to Philip Alcabes Philip Alcabes (= 1×) peers G. Friedland

Countries citing papers authored by Philip Alcabes

Since Specialization

Citations

This map shows the geographic impact of Philip Alcabes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Alcabes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Alcabes more than expected).

Fields of papers citing papers by Philip Alcabes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Alcabes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Alcabes. The network helps show where Philip Alcabes may publish in the future.

Co-authorship network of co-authors of Philip Alcabes

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Alcabes. A scholar is included among the top collaborators of Philip Alcabes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Alcabes. Philip Alcabes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alcabes, Philip. (2006). The risky gene: epidemiology and the evolution of race. Patterns of Prejudice. 40(4-5). 413–425.

Condos, Rany & Philip Alcabes. (2003). Does Diabetes Predispose to the Development of Multidrug-Resistant Tuberculosis?. CHEST Journal. 123(1). 309–309. 5 indexed citations

Kuljiš, Rodrigo O., et al.. (2003). Increased Density of Neurons Containing NADPH Diaphorase and Nitric Oxide Synthase in the Cerebral Cortex of Patients with HIV-1 Infection and Drug Abuse. 2(3). 19–36. 9 indexed citations

Chandramuki, A, Konstantin P. Lyashchenko, Neelam Khanna, et al.. (2002). Detection of Antibody toMycobacterium tuberculosisProtein Antigens in the Cerebrospinal Fluid of Patients with Tuberculous Meningitis. The Journal of Infectious Diseases. 186(5). 678–683. 27 indexed citations

Davidow, Amy L., Philip Alcabes, & Michael Marmor. (2000). The Contribution of Recently Acquired Mycobacterium tuberculosis Infection to the New York City Tuberculosis Epidemic, 1989–1993. Epidemiology. 11(4). 394–401. 1 indexed citations

Fontanarosa, Phil, Pablo Bifani, Bo Shopsin, et al.. (2000). Molecular Epidemiology and Tuberculosis Control—Reply. JAMA. 284(3). 306–306. 1 indexed citations

Davidow, Amy L., Michael Marmor, & Philip Alcabes. (1997). Geographic Diversity in Tuberculosis Trends and Directly Observed Therapy, New York City, 1991 to 1994. American Journal of Respiratory and Critical Care Medicine. 156(5). 1495–1500. 12 indexed citations

Williams, Ann B., et al.. (1997). Social support for HIV-infected mothers: Relation to HIV care seeking. Journal of the Association of Nurses in AIDS Care. 8(1). 91–98. 11 indexed citations

Wetherill, Patricia E., Marie L. Landry, Philip Alcabes, & Gerald Friedland. (1996). Use of a Quantitative Cytomegalovirus (CMV) Antigenemia Test in Evaluating HIV+ Patients with and without CMV Disease. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 12(1). 33–37. 24 indexed citations

10.

Alcabes, Philip, Peter A. Selwyn, Katherine Davenny, et al.. (1994). Laboratory markers and the risk of developing HIV-1 disease among injecting drug users. AIDS. 8(1). 107–116. 8 indexed citations

11.

Alcabes, Philip, Álvaro Muñoz, David Vlahov, & Gerald Friedland. (1994). Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users. Annals of Epidemiology. 4(1). 17–26. 19 indexed citations

12.

Alcabes, Philip, Ellie E. Schoenbaum, & Robert S. Klein. (1993). Correlates of the Rate of Decline of CD4+ Lymphocytes among Injection Drug Users Infected with the Human Immunodeficiency Virus. American Journal of Epidemiology. 137(9). 989–1000. 25 indexed citations

13.

Alcabes, Philip, et al.. (1993). CD4+ lymphocyte level and rate of decline as predictors of AIDS in intravenous drug users with HIV infection. AIDS. 7(4). 513–518. 8 indexed citations

14.

Alcabes, Philip, Álvaro Muñoz, David Vlahov, & Gerald Friedland. (1993). Incubation Period of Human Immunodeficiency Virus. Epidemiologic Reviews. 15(2). 303–318. 51 indexed citations

15.

Arno, Peter S., Christopher J L Murray, Karen Bonuck, & Philip Alcabes. (1993). The Economic Impact of Tuberculosis in Hospitals in New York City: A Preliminary Analysis. The Journal of Law Medicine & Ethics. 21(3-4). 317–323. 25 indexed citations

16.

Alcabes, Philip, David Vlahov, & James C. Anthony. (1992). Characteristics of Intravenous Drug Users by History of Arrest and Treatment for Drug Use. The Journal of Nervous and Mental Disease. 180(1). 48–54. 18 indexed citations

17.

Selwyn, Peter A., Philip Alcabes, Diana Hartel, et al.. (1992). Clinical Manifestations and Predictors of Disease Progression in Drug Users with Human Immunodeficiency Virus Infection. New England Journal of Medicine. 327(24). 1697–1703. 243 indexed citations

18.

Alcabes, Philip, David Vlahov, & James C. Anthony. (1992). Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment‐program samples misleading?. British Journal of Addiction. 87(1). 47–54. 23 indexed citations

19.

Alcabes, Philip, et al.. (1989). Compliance with Isoniazid Prophylaxis in Jail. American Review of Respiratory Disease. 140(5). 1194–1197. 28 indexed citations

20.

Alcabes, Philip, et al.. (1988). An Outbreak of Salmonella Gastroenteritis in an Urban Jail. Infection Control and Hospital Epidemiology. 9(12). 542–547. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact